Clinical Study Results
What were the results of the study?
This is a summary of the main results from this study overall. The results each participant
had might be different and are not in this summary. A full list of the questions researchers
wanted to answer can be found on the websites listed at the end of this summary. When
a full report of the study results is available, it can also be found on these websites.
Researchers look at the results of many studies to decide which treatments work best
and are safest. Other studies may provide new information or different results. Always talk
to a doctor before making any treatment changes.
Did fewer participants who took ticagrelor have a stroke or die within 30 days
of taking study treatment?
Yes. Overall, the researchers found that there were fewer participants who took ticagrelor
who had strokes or died within 30 days of taking study treatment compared to the
participants who took the placebo.
To answer this question, the researchers compared the number of participants who had a
stroke or died within 30 days of taking either ticagrelor or the placebo.
Overall, the researchers found that within 30 days of taking study treatment:
• 5.4% of the participants who took ticagrelor and ASA had a stroke or died. This was
303 out of 5,523 participants.
• 6.5% of the participants who took the placebo and ASA had a stroke or died. This
was 362 out of 5,493 participants.
7